Abstract
Purpose
To investigate the incidence and characteristics of subsequent vertebral fracture after osteoporotic vertebral fractures (OVFs) and identify risk factors for subsequent vertebral fractures.
Methods
This post-hoc analysis from a prospective randomized multicenter trial included 225 patients with a 48-week follow-up period. Differences between the subsequent and non-subsequent fracture groups were analyzed.
Results
Of the 225 patients, 15 (6.7%) had a subsequent fracture during the 48-week follow-up. The annual incidence of subsequent vertebral fracture after fresh OVFs in women aged 65–85 years was 68.8 per 1000 person-years. Most patients (73.3%) experienced subsequent vertebral fractures within 6 months. At 48 weeks, European Quality of Life-5 Dimensions, the Japanese Orthopedic Association Back Pain Evaluation Questionnaire pain-related disorder, walking ability, social life function, and lumbar function scores were significantly lower, while the visual analog scale (VAS) for low back pain was higher in patients with subsequent fracture. Cox proportional hazards analysis showed that a VAS score ≥ 70 at 0 weeks was an independent predictor of subsequent vertebral fracture. After adjustment for history of previous fracture, there was a ~ 67% reduction in the risk of subsequent vertebral fracture at the rigid-brace treatment.
Conclusion
Women with a fresh OVF were at higher risk for subsequent vertebral fracture within the next year. Severe low back pain and use of soft braces were associated with higher risk of subsequent vertebral fractures. Therefore, when treating patients after OVFs with these risk factors, more attention may be needed for the occurrence of subsequent vertebral fractures.
Level of evidence
III
Similar content being viewed by others
References
Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, Curtis JR (2019) Risk of subsequent fracture after prior fracture among older women. Osteoporos Int 30:79–92. https://doi.org/10.1007/s00198-018-4732-1
Banefelt J, Akesson KE, Spangeus A, Ljunggren O, Karlsson L, Strom O, Ortsater G, Libanati C, Toth E (2019) Risk of imminent fracture following a previous fracture in a Swedish database study. Osteoporosis Int 30:601–609. https://doi.org/10.1007/s00198-019-04852-8
van Geel TA, van Helden S, Geusens PP, Winkens B, Dinant GJ (2009) Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis 68:99–102. https://doi.org/10.1136/ard.2008.092775
Jinbayashi H, Aoyagi K, Ross PD, Ito M, Shindo H, Takemoto T (2002) Prevalence of vertebral deformity and its associations with physical impairment among Japanese women: the Hizen-Oshima Study. Osteoporosis Int 13:723–730. https://doi.org/10.1007/s001980200099
Bliuc D, Alarkawi D, Nguyen TV, Eisman JA, Center JR (2015) Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis epidemiology study. J Bone Miner Res 30:637–646. https://doi.org/10.1002/jbmr.2393
van Staa TP, Dennison EM, Leufkens HG, Cooper C (2001) Epidemiology of fractures in England and Wales. Bone 29:517–522. https://doi.org/10.1016/s8756-3282(01)00614-7
Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285:320–323. https://doi.org/10.1001/jama.285.3.320
Kato T, Inose H, Ichimura S, Tokuhashi Y, Nakamura H, Hoshino M, Togawa D, Hirano T, Haro H, Ohba T, Tsuji T, Sato K, Sasao Y, Takahata M, Otani K, Momoshima S, Tateishi U, Tomita M, Takemasa R, Yuasa M, Hirai T, Yoshii T, Okawa A (2019) Comparison of rigid and soft-brace treatments for acute osteoporotic vertebral compression fracture: a prospective, randomized. Multicenter Study J Clin Med. https://doi.org/10.3390/jcm8020198
(1990) EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 16:199–208. doi: https://doi.org/10.1016/0168-8510(90)90421-9
McCormack HM, Horne DJ, Sheather S (1988) Clinical applications of visual analogue scales: a critical review. Psychol Med 18:1007–1019. https://doi.org/10.1017/s0033291700009934
Fukui M, Chiba K, Kawakami M, Kikuchi S, Konno S, Miyamoto M, Seichi A, Shimamura T, Shirado O, Taguchi T, Takahashi K, Takeshita K, Tani T, Toyama Y, Yonenobu K, Wada E, Tanaka T, Hirota Y (2009) JOA back pain evaluation questionnaire (JOABPEQ)/JOA cervical myelopathy evaluation questionnaire (JOACMEQ). The report on the development of revised versions. April 16, 2007. The subcommittee of the clinical outcome committee of the Japanese orthopaedic association on low back pain and cervical myelopathy evaluation. J Orthop Sci 14:348–365. https://doi.org/10.1007/s00776-009-1337-8
Keynan O, Fisher CG, Vaccaro A, Fehlings MG, Oner FC, Dietz J, Kwon B, Rampersaud R, Bono C, France J, Dvorak M (2006) Radiographic measurement parameters in thoracolumbar fractures: a systematic review and consensus statement of the spine trauma study group. Spine 31:E156-165. https://doi.org/10.1097/01.brs.0000201261.94907.0d
Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The study of osteoporotic fractures research group. J Bone Miner Res 11:984–996. https://doi.org/10.1002/jbmr.5650110716
Fujiwara S, Kasagi F, Masunari N, Naito K, Suzuki G, Fukunaga M (2003) Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res 18:1547–1553. https://doi.org/10.1359/jbmr.2003.18.8.1547
Aubrun F, Langeron O, Quesnel C, Coriat P, Riou B (2003) Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration. Anesthesiology 98:1415–1421. https://doi.org/10.1097/00000542-200306000-00017
Kelly A (2001) The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J EMJ 18:205–207. https://doi.org/10.1136/emj.18.3.205
Ohtori S, Ito T, Yamashita M, Murata Y, Morinaga T, Hirayama J, Kinoshita T, Ataka H, Koshi T, Sekikawa T, Miyagi M, Tanno T, Suzuki M, Aoki Y, Aihara T, Nakamura S, Yamaguchi K, Tauchi T, Hatakeyama K, Takata K, Sameda H, Ozawa T, Hanaoka E, Suzuki H, Akazawa T, Suseki K, Arai H, Kurokawa M, Eguchi Y, Suzuki M, Okamoto Y, Miyagi J, Yamagata M, Toyone T, Takahashi K (2010) Evaluation of low back pain using the Japanese Orthopaedic Association Back Pain Evaluation Questionnaire for lumbar spinal disease in a multicenter study: differences in scores based on age, sex, and type of disease. Journal of Orthop Sci 15:86–91. https://doi.org/10.1007/s00776-009-1426-8
M. Versteegh M, M. Vermeulen K, M. A. A. Evers S, de Wit GA, Prenger R, A. Stolk E, (2016) Dutch tariff for the five-level version of EQ-5D. Value Health 19:343–352. https://doi.org/10.1016/j.jval.2016.01.003
Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458. https://doi.org/10.1038/bmt.2012.244
Ihaka R, Gentleman R (1996) R: A language for data analysis and graphics. J Comput Gr Stat 5:299–314. https://doi.org/10.1080/10618600.1996.10474713
Molvik H, Khan W (2015) Bisphosphonates and their influence on fracture healing: a systematic review. Osteopor Int 26:1251–1260. https://doi.org/10.1007/s00198-014-3007-8
Tsuchie H, Miyakoshi N, Kasukawa Y, Nishi T, Abe H, Segawa T, Shimada Y (2016) The effect of teriparatide to alleviate pain and to prevent vertebral collapse after fresh osteoporotic vertebral fracture. J Bone Miner Metab 34:86–91. https://doi.org/10.1007/s00774-014-0646-y
Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT research group. J Clin Endocrinol Metab 85:4118–4124. https://doi.org/10.1210/jcem.85.11.6953
Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. New England J Med 356:1809–1822. https://doi.org/10.1056/NEJMoa067312
Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. New England J Med 361:756–765. https://doi.org/10.1056/NEJMoa0809493
Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A, Zerbini CA, Milmont CE, Chen L, Maddox J, Meisner PD, Libanati C, Grauer A (2016) Romosozumab Treatment in postmenopausal women with osteoporosis. New England J Med 375:1532–1543. https://doi.org/10.1056/NEJMoa1607948
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. New England J Med 344:1434–1441. https://doi.org/10.1056/nejm200105103441904
Briggs AM, Wrigley TV, van Dieën JH, Phillips B, Lo SK, Greig AM, Bennell KL (2006) The effect of osteoporotic vertebral fracture on predicted spinal loads in vivo. Eur Spine J 15:1785–1795. https://doi.org/10.1007/s00586-006-0158-0
Keller TS, Harrison DE, Colloca CJ, Harrison DD, Janik TJ (2003) Prediction of osteoporotic spinal deformity. Spine 28:455–462. https://doi.org/10.1097/01.Brs.0000048651.92777.30
Spector ER, Smith SM, Sibonga JD (2009) Skeletal effects of long-duration head-down bed rest. Aviat Space Environ Med 80:A23-28. https://doi.org/10.3357/asem.br02.2009
Yamauchi K, Adachi A, Kameyama M, Murakami M, Sato Y, Kato C, Kato T (2020) A risk factor associated with subsequent new vertebral compression fracture after conservative therapy for patients with vertebral compression fracture: a retrospective observational study. Arch Osteop 15:9. https://doi.org/10.1007/s11657-019-0679-x
Lyritis GP, Mayasis B, Tsakalakos N, Lambropoulos A, Gazi S, Karachalios T, Tsekoura M, Yiatzides A (1989) The natural history of the osteoporotic vertebral fracture. Clin Rheumatol 8(Suppl 2):66–69. https://doi.org/10.1007/bf02207237
Buchalter D, Kahanovitz N, Viola K, Dorsky S, Nordin M (1988) Three-dimensional spinal motion measurements. Part 2: A noninvasive assessment of lumbar brace immobilization of the spine. J Spinal Disord 1:284–286. https://doi.org/10.1097/00002517-198800140-00001
Lantz SA, Schultz AB (1986) Lumbar spine orthosis wearing. I Restriction of gross body motions. Spine 11:834–837. https://doi.org/10.1097/00007632-198610000-00019
Roux C, Briot K (2017) Imminent fracture risk. Osteopor Int 28:1765–1769. https://doi.org/10.1007/s00198-017-3976-5
Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382. https://doi.org/10.1016/j.bone.2004.03.024
Santiago FR, Muñoz PT, Sánchez EM, Paniza MR, Martínez AM, Abela ALP (2016) Classifying thoracolumbar fractures: role of quantitative imaging. Quant Imaging Med Surg 6:772–784. https://doi.org/10.21037/qims.2016.12.04
Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) study group. JAMA 282:1344–1352. https://doi.org/10.1001/jama.282.14.1344
Acknowledgements
The authors thank Tomoko Nakajima for her help with data collection, Dr. Makoto Tomita for his help with the statistical analysis, and Dr. Ukihide Tateishi for his help with the radiological analysis.
Funding
None declared.
Author information
Authors and Affiliations
Contributions
Hiroyuki Inose, Tsuyoshi Kato, Shoichi Ichimura, Hiroaki Nakamura, Masatoshi Hoshino, Daisuke Togawa, Toru Hirano, Yasuaki Tokuhashi, Tetsuro Ohba, Hirotaka Haro, Takashi Tsuji, Kimiaki Sato, Yutaka Sasao, Masahiko Takahata, Koji Otani, Suketaka Momoshima, Kunihiko Takahashi, Masato Yuasa, Takashi Hirai, Toshitaka Yoshii, and Atsushi Okawa (1) provided substantial contributions to the conception or design of the study or the acquisition, analysis, or interpretation of data; (2) drafted the paper or revised it critically for important intellectual content, (3) provided final approval of the version to be published; and (4) agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
This study was approved by the institutional review board at the Tokyo Medical and Dental University and was compliant with the Declaration of Helsinki.
Availability of data and material
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Inose, H., Kato, T., Ichimura, S. et al. Risk factors for subsequent vertebral fracture after acute osteoporotic vertebral fractures. Eur Spine J 30, 2698–2707 (2021). https://doi.org/10.1007/s00586-021-06741-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-021-06741-3